dipeptide alanyl-glutamine
Peptideexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2010 (NCT00922688)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetSupplementation
supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dipeptide alanyl-glutamine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05586646 | N/A | Apr 1, 2022 | Government of Egypt, United States Air Force |
| NCT04305769 | Phase 2 | Aug 31, 2020 | Imperial College London, University of Virginia |
| NCT00922688 | N/A | Dec 1, 2010 | Noordwest Ziekenhuisgroep |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Egypt | Government | 1 | 1 | 1 | 2022 |
| Imperial College London | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Noordwest Ziekenhuisgroep | Academic/Hospital | 1 | 1 | 1 | 2010 |
| United States Air Force | Government | 1 | 0 | 1 | 2022 |
| University of Virginia | Academic/Hospital | 1 | 1 | 1 | 2020 |
5 organizations
Page 1 / 1